🇺🇸 FDA
Patent

US 8501957

Benzimidazole compounds and their use as anticancer agents

granted A61KA61K31/4184A61K31/4439

Quick answer

US patent 8501957 (Benzimidazole compounds and their use as anticancer agents) held by China Medical University expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4184, A61K31/4439, A61K31/454, A61K31/496